Abstract
Lung transplantation represents an option for patients with a variety of end-stage lung diseases. While surgical advances have led to improvements in short-term survival, long-term survival is limited by chronic rejection termed bronchiolitis obliterans syndrome (BOS). A growing body of work is devoted to determining why some patients develop BOS. One avenue of interest that has emerged recently is the role that regulatory T cells (Tregs) may have in protection from BOS. In this review, we will discuss the evidence that Tregs are relevant to outcomes following transplant. We will discuss the relevant animal models, in vitro assays, and human observational studies that support a role for Tregs. We will also explore the interplay between injurious T cells such as Th17 cells and Tregs as well as the effect that additional cell types and chemokines have on the balance between inflammation and regulation. Finally, we will review emerging therapies which may harness the ability of Tregs to lessen the effects of BOS.
Similar content being viewed by others
References
Christie JD, Edwards LB, Aurora P et al (2009) The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report-2009. J Heart Lung Transplant 28:1031–1049
Zheng XX, Sanchez-Fueyo A, Domenig C, Strom TB (2003) The balance of deletion and regulation in allograft tolerance. Immunol Rev 196:75–84
Lerut J, Sanchez-Fueyo A (2006) An appraisal of tolerance in liver transplantation. Am J Transplant 6:1774–1780
Martinez-Llordella M, Puig-Pey I, Orlando G et al (2007) Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 7:309–319
Bennett CL, Christie J, Ramsdell F et al (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27:20–21
Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057–1061
Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat Immunol 4:330–336
von Boehmer H (2005) Mechanisms of suppression by suppressor T cells. Nat Immunol 6:338–344
Carrier Y, Yuan J, Kuchroo VK, Weiner HL (2007) Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. J Immunol 178:179–185
Kay AB (2001) Allergy and allergic diseases. First of two parts. N Engl J Med 344:30–37
Haldar P, Pavord ID, Shaw DE et al (2008) Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 178:218–224
Molet S, Hamid Q, Davoine F et al (2001) IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 108:430–438
Wakashin H, Hirose K, Maezawa Y et al (2008) IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 178:1023–1032
Hartl D, Koller B, Mehlhorn AT et al (2007) Quantitative and functional impairment of pulmonary CD4+ CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol 119:1258–1266
Kearley J, Barker JE, Robinson DS, Lloyd CM (2005) Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+ CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med 202:1539–1547
Kearley J, Robinson DS, Lloyd CM (2008) CD4+ CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J Allergy Clin Immunol 122:617.e6–624.e6
Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med 342:1334–1349
Rubenfeld GD, Caldwell E, Peabody E et al (2005) Incidence and outcomes of acute lung injury. N Engl J Med 353:1685–1693
D'Alessio FR, Tsushima K, Aggarwal NR et al (2009) CD4+ CD25+ Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest 119:2898–2913
Haque MA, Mizobuchi T, Yasufuku K et al (2002) Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J Immunol 169:1542–1549
Yasufuku K, Heidler KM, O'Donnell PW et al (2001) Oral tolerance induction by type V collagen downregulates lung allograft rejection. Am J Respir Cell Mol Biol 25:26–34
Yasufuku K, Heidler KM, Woods KA et al (2002) Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance. Transplantation 73:500–505
Lauer-Fields JL, Sritharan T, Stack MS, Nagase H, Fields GB (2003) Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9. J Biol Chem 278:18140–18145
Beeh KM, Beier J, Kornmann O, Micke P, Buhl R (2001) Sputum levels of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, and their ratio correlate with airway obstruction in lung transplant recipients: relation to tumor necrosis factor-alpha and interleukin-10. J Heart Lung Transplant 20:1144–1151
Taghavi S, Krenn K, Jaksch P, Klepetko W, Aharinejad S (2005) Broncho-alveolar lavage matrix metalloproteases as a sensitive measure of bronchiolitis obliterans. Am J Transplant 5:1548–1552
Hubner RH, Meffert S, Mundt U et al (2005) Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation. Eur Respir J 25:494–501
Soccal PM, Gasche Y, Miniati DN et al (2004) Matrix metalloproteinase inhibition decreases ischemia-reperfusion injury after lung transplantation. Am J Transplant 4:41–50
Bharat A, Fields RC, Trulock EP, Patterson GA, Mohanakumar T (2006) Induction of IL-10 suppressors in lung transplant patients by CD4+ 25+ regulatory T cells through CTLA-4 signaling. J Immunol 177:5631–5638
Stassen M, Fondel S, Bopp T et al (2004) Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells. Eur J Immunol 34:1303–1311
Bharat A, Fields RC, Steward N, Trulock EP, Patterson GA, Mohanakumar T (2006) CD4+ 25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am J Transplant 6:1799–1808
Mizobuchi T, Yasufuku K, Zheng Y et al (2003) Differential expression of Smad7 transcripts identifies the CD4+ CD45RChigh regulatory T cells that mediate type V collagen-induced tolerance to lung allografts. J Immunol 171:1140–1147
Jiang S, Lechler RI, He XS, Huang JF (2006) Regulatory T cells and transplantation tolerance. Hum Immunol 67:765–776
Yamada Y, Sekine Y, Yoshida S et al (2009) Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts. J Immunol 183:237–245
Burlingham WJ, Love RB, Jankowska-Gan E et al (2007) IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 117:3498–3506
Valencia X, Stephens G, Goldbach-Mansky R, Wilson M, Shevach EM, Lipsky PE (2006) TNF downmodulates the function of human CD4+ CD25hi T-regulatory cells. Blood 108:253–261
O’Sullivan BJ, Thomas HE, Pai S et al (2006) IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. J Immunol 176:7278–7287
Bettelli E, Carrier Y, Gao W et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235–238
Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179–189
Mangan PR, Harrington LE, O'Quinn DB et al (2006) Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441:231–234
Deknuydt F, Bioley G, Valmori D, Ayyoub M (2009) IL-1beta and IL-2 convert human Treg into T(H)17 cells. Clin Immunol 131:298–307
Osorio F, LeibundGut-Landmann S, Lochner M et al (2008) DC activated via dectin-1 convert Treg into IL-17 producers. Eur J Immunol 38:3274–3281
Koenen HJ, Smeets RL, Vink PM, van Rijssen E, Boots AM, Joosten I (2008) Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112:2340–2352
Jaffar Z, Ferrini ME, Girtsman TA, Roberts K (2009) Antigen-specific Treg regulate Th17-mediated lung neutrophilic inflammation, B-cell recruitment and polymeric IgA and IgM levels in the airways. Eur J Immunol 39:3307–3314
Studer SM, George MP, Zhu X et al (2008) CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients. Am J Respir Crit Care Med 178:765–773
Tai X, Cowan M, Feigenbaum L, Singer A (2005) CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 6:152–162
Meloni F, Vitulo P, Bianco AM et al (2004) Regulatory CD4+ CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome. Transplantation 77:762–766
Zeiser R, Nguyen VH, Beilhack A et al (2006) Inhibition of CD4+ CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 108:390–399
Botturi K, Lacoeuille Y, Thomas P, Boniface S, Reynaud-Gaubert M, Magnan A (2008) CTLA-4-mediated regulatory phenotype of T-cells in tolerant lung recipients. Eur Respir J 31:1167–1176
Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA (2000) Indoleamine 2, 3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 164:3596–3599
Meloni F, Giuliano S, Solari N et al (2009) Indoleamine 2, 3-dioxygenase in lung allograft tolerance. J Heart Lung Transplant 28:1185–1192
Gregson AL, Hoji A, Saggar R et al (2008) Bronchoalveolar immunologic profile of acute human lung transplant allograft rejection. Transplantation 85:1056–1059
Neujahr DC, Cardona AC, Ulukpo O et al (2009) Dynamics of human regulatory T cells in lung lavages of lung transplant recipients. Transplantation 88:521–527
Bestard O, Cruzado JM, Rama I et al (2008) Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol 19:2020–2026
Muthukumar T, Dadhania D, Ding R et al (2005) Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 353:2342–2351
Gavin MA, Torgerson TR, Houston E et al (2006) Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 103:6659–6664
Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE (2007) Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 37:129–138
Janson PC, Winerdal ME, Marits P, Thorn M, Ohlsson R, Winqvist O (2008) FOXP3 promoter demethylation reveals the committed Treg population in humans. PLoS ONE 3(2):e1612
Mamessier E, Lorec AM, Thomas P, Badier M, Magnan A, Reynaud-Gaubert M (2007) T regulatory cells in stable posttransplant bronchiolitis obliterans syndrome. Transplantation 84:908–916
Belperio JA, Keane MP, Burdick MD et al (2003) Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection. J Immunol 171:4844–4852
Yang ZZ, Novak AJ, Stenson MJ, Witzig TE, Ansell SM (2006) Intratumoral CD4+ CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 107:3639–3646
Curiel TJ, Coukos G, Zou L et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942–949
Maeda A, Schwarz A, Kernebeck K et al (2005) Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 174:5968–5976
Maeda A, Schwarz A, Bullinger A, Morita A, Peritt D, Schwarz T (2008) Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: generation of IL-10 and induction of regulatory T cells. J Immunol 181:5956–5962
Bladon J, Taylor P (2002) Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo. J Clin Apher 17:177–182
Rao V, Saunes M, Jorstad S, Moen T (2009) Cutaneous T cell lymphoma and graft-versus-host disease: a comparison of in vivo effects of extracorporeal photochemotherapy on Foxp3+ regulatory T cells. Clin Immunol 133:303–313
Schmitt S, Johnson TS, Karakhanova S, Naher H, Mahnke K, Enk AH (2009) Extracorporeal photophoresis augments function of CD4+ CD25+ FoxP3+ regulatory T cells by triggering adenosine production. Transplantation 88:411–416
Morrell MR, Despotis GJ, Lublin DM, Patterson GA, Trulock EP, Hachem RR (2009) The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 29:424–431
Meloni F, Cascina A, Miserere S, Perotti C, Vitulo P, Fietta AM (2007) Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients. Transplant Proc 39:213–217
Bluestone JA (2005) CTLA-4Ig is finally making it: a personal perspective. Am J Transplant 5:423–424
Lohr J, Knoechel B, Abbas AK (2006) Regulatory T cells in the periphery. Immunol Rev 212:149–162
Tang Q, Henriksen KJ, Boden EK et al (2003) Cutting edge: CD28 controls peripheral homeostasis of CD4+ CD25+ regulatory T cells. J Immunol 171:3348–3352
Okazaki M, Sugimoto S, Lai J et al (2009) Costimulatory blockade-mediated lung allograft acceptance is abrogated by overexpression of Bcl-2 in the recipient. Transplant Proc 41:385–387
Bluestone JA, Liu W, Yabu JM et al (2008) The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation. Am J Transplant 8:2086–2096
Vincenti F, Charpentier B, Vanrenterghem Y et al (2010) A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant 10:535–546
Dao Nguyen X, Robinson DS (2004) Fluticasone propionate increases CD4CD25 T regulatory cell suppression of allergen-stimulated CD4CD25 T cells by an IL-10-dependent mechanism. J Allergy Clin Immunol 114:296–301
Karagiannidis C, Akdis M, Holopainen P et al (2004) Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 114:1425–1433
Peek EJ, Richards DF, Faith A et al (2005) Interleukin-10-secreting "regulatory" T cells induced by glucocorticoids and beta2-agonists. Am J Respir Cell Mol Biol 33:105–111
Xystrakis E, Kusumakar S, Boswell S et al (2006) Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 116:146–155
Yeh SH, Chuang H, Lin LW et al (2009) Regular Tai Chi Chuan exercise improves T cell helper function of patients with type 2 diabetes mellitus with an increase in T-bet transcription factor and IL-12 production. Br J Sports Med 43:845–850
Lowder T, Dugger K, Deshane J, Estell K, Schwiebert LM (2010) Repeated bouts of aerobic exercise enhance regulatory T cell responses in a murine asthma model. Brain Behav Immun 24:153–159
Bergeron A, Belle A, Chevret S et al (2007) Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation. Bone Marrow Transplant 39:547–553
De Soyza A, Fisher AJ, Small T, Corris PA (2001) Inhaled corticosteroids and the treatment of lymphocytic bronchiolitis following lung transplantation. Am J Respir Crit Care Med 164:1209–1212
Acknowledgments
Dr. Neujahr is supported by a grant from the Roche Organ Transplant Research Foundation and by an NIH Career Development Award.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published as part of the Special Issue on Transplantation and Tolerance
Rights and permissions
About this article
Cite this article
Neujahr, D.C., Larsen, C.P. Regulatory T cells in lung transplantation—an emerging concept. Semin Immunopathol 33, 117–127 (2011). https://doi.org/10.1007/s00281-011-0253-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00281-011-0253-0